Anti-TB drug resistance in strains of Mycobacterium tuberculosis complex in Southeast Spain.
The aim of this study is to determine the resistance to anti-TB drugs of Mycobacterium tuberculosis strains isolated from patients diagnosed in southeast Spain, and to study related epidemiological factors. This retrospective study analyses five-year data obtained in southeast Spain for a total equivalent population of 1,735,608 inhabitants. Clinical samples were examined from 557 patients with suspected pulmonary (n = 470; 84.4%) or extrapulmonary (n = 87; 15.6%) tuberculosis, taking into account age, sex, HIV infection, country of birth and prior-treatment. Tuberculosis was found more frequently in men than in women; the age range producing most cases was that of patients aged 36-55 years (43.7%). Among first-line drugs, 7% of patients were resistant to isoniazid and 1.6% to rifampicin; 1.4% was multi-resistant and 0.5%, extensively drug resistant. There was a statistically significant relationship (p = 0.028) between multi-resistance and non-Spanish-born patients, but not between the latter and isoniazid resistance. Resistance to isoniazid and rifampicin was observed at levels similar to those published nationwide, with rates of multi-resistance being somewhat lower. Rates of HIV-tuberculosis co-infection have decreased considerably.